Immunocore Holdings (IMCR) reported Q1 net income Wednesday of $0.10 per diluted share, swinging from a loss of $0.49 a year earlier.
Analysts polled by FactSet expected a loss of $0.38.
Revenue for the quarter ended March 31 was $93.9 million, up from $70.5 million a year earlier.
Analysts surveyed by FactSet expected $86.5 million.
The company said that as of March 31, it has $837 million in cash, cash equivalents and marketable securities.
Shares of the company were up 2.6% in recent Wednesday premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。